Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2C KMT2A KMT2D	4.80e-05	8	193	3	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2C KMT2A KMT2D	1.01e-04	10	193	3	GO:0140999
GeneOntologyBiologicalProcess	stress fiber assembly	SYNPO ALMS1 ARHGEF5 KANK2 TESK1 FAM171A1 FHDC1 PHLDB2	2.84e-05	127	195	8	GO:0043149
GeneOntologyBiologicalProcess	contractile actin filament bundle assembly	SYNPO ALMS1 ARHGEF5 KANK2 TESK1 FAM171A1 FHDC1 PHLDB2	2.84e-05	127	195	8	GO:0030038
GeneOntologyCellularComponent	histone methyltransferase complex	EED KMT2C KMT2A BOD1L1 HCFC2 UTY KMT2D	6.20e-06	75	194	7	GO:0035097
GeneOntologyCellularComponent	methyltransferase complex	EED KMT2C KMT2A BOD1L1 HCFC2 UTY KMT2D	6.73e-05	108	194	7	GO:0034708
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C UTY KMT2D	1.63e-04	12	194	3	GO:0044666
GeneOntologyCellularComponent	lamellipodium	RAPH1 DAG1 PTPN13 PLD1 ABI1 SRCIN1 TESK1 FGD6 MTSS2	3.09e-04	230	194	9	GO:0030027
Domain	FYrich_C	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	IPR003889
Domain	FYrich_N	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	IPR003888
Domain	FYRC	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	SM00542
Domain	FYRN	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	SM00541
Domain	FYRN	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	PF05964
Domain	FYRC	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	PF05965
Domain	FYRC	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	PS51543
Domain	FYRN	KMT2C KMT2A KMT2D	1.04e-05	5	191	3	PS51542
Domain	-	DAB2IP RAPH1 ARHGEF11 GAB2 SPTBN5 PTPN13 TBC1D1 PLD1 ARHGEF5 ARHGEF12 DCP1B TNS1 FGD6 PHLDB2	5.22e-05	391	191	14	2.30.29.30
Domain	PDZ	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.03e-04	141	191	8	PF00595
Domain	Filaggrin	FLG2 FLG	1.04e-04	2	191	2	IPR003303
Domain	PH_dom-like	DAB2IP RAPH1 ARHGEF11 GAB2 SPTBN5 PTPN13 TBC1D1 PLD1 ARHGEF5 ARHGEF12 DCP1B TNS1 FGD6 PHLDB2	1.29e-04	426	191	14	IPR011993
Domain	PDZ	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.44e-04	148	191	8	SM00228
Domain	AT_hook	KMT2C KMT2A BOD1L1 BAZ2A	1.55e-04	27	191	4	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2C KMT2A BOD1L1 BAZ2A	1.55e-04	27	191	4	IPR017956
Domain	-	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.58e-04	150	191	8	2.30.42.10
Domain	PDZ	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.65e-04	151	191	8	PS50106
Domain	PDZ	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.73e-04	152	191	8	IPR001478
Domain	ANK_REPEAT	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 MUC16 PPP1R13B TEX14 KANK2 TANC1	2.86e-04	253	191	10	PS50088
Domain	ANK_REP_REGION	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 MUC16 PPP1R13B TEX14 KANK2 TANC1	2.96e-04	254	191	10	PS50297
Domain	RGS-like_dom	ARHGEF11 ARHGEF12	3.10e-04	3	191	2	IPR015212
Domain	RGS-like	ARHGEF11 ARHGEF12	3.10e-04	3	191	2	PF09128
Domain	Ankyrin_rpt	ANKRD31 RAPH1 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	3.78e-04	262	191	10	IPR002110
Domain	Ank_2	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	3.80e-04	215	191	9	PF12796
Domain	Post-SET_dom	KMT2C KMT2A KMT2D	5.34e-04	16	191	3	IPR003616
Domain	PostSET	KMT2C KMT2A KMT2D	5.34e-04	16	191	3	SM00508
Domain	AT_hook	KMT2C KMT2A BAZ2A	5.34e-04	16	191	3	PF02178
Domain	POST_SET	KMT2C KMT2A KMT2D	5.34e-04	16	191	3	PS50868
Domain	Ank	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	5.81e-04	228	191	9	PF00023
Domain	PH	DAB2IP RAPH1 ARHGEF11 GAB2 SPTBN5 PLD1 ARHGEF5 ARHGEF12 FGD6 PHLDB2	6.00e-04	278	191	10	SM00233
Domain	Amidase_domain	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	IPR002502
Domain	PGRP	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	SM00701
Domain	Amidase_2	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	PF01510
Domain	Shroom_fam	SHROOM4 SHROOM3	6.16e-04	4	191	2	IPR027685
Domain	ASD2_dom	SHROOM4 SHROOM3	6.16e-04	4	191	2	IPR014799
Domain	ASD2	SHROOM4 SHROOM3	6.16e-04	4	191	2	PF08687
Domain	Ami_2	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	SM00644
Domain	-	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	3.40.80.10
Domain	ASD2	SHROOM4 SHROOM3	6.16e-04	4	191	2	PS51307
Domain	PGRP_domain_met/bac	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	IPR006619
Domain	PGRP	PGLYRP2 PGLYRP4	6.16e-04	4	191	2	IPR015510
Domain	PH_DOMAIN	DAB2IP RAPH1 ARHGEF11 GAB2 SPTBN5 PLD1 ARHGEF5 ARHGEF12 FGD6 PHLDB2	6.17e-04	279	191	10	PS50003
Domain	PH_domain	DAB2IP RAPH1 ARHGEF11 GAB2 SPTBN5 PLD1 ARHGEF5 ARHGEF12 FGD6 PHLDB2	6.34e-04	280	191	10	IPR001849
Domain	Znf_FYVE_PHD	KMT2C KMT2A BSN KMT2D BAZ2A SYTL5 FGD6	8.00e-04	147	191	7	IPR011011
Domain	TF_AP2	TFAP2A TFAP2B	1.02e-03	5	191	2	IPR004979
Domain	NUT	NUTM2A NUTM2B	1.02e-03	5	191	2	IPR024310
Domain	NUT_N	NUTM2A NUTM2B	1.02e-03	5	191	2	IPR024309
Domain	TF_AP2_C	TFAP2A TFAP2B	1.02e-03	5	191	2	IPR013854
Domain	NUT	NUTM2A NUTM2B	1.02e-03	5	191	2	PF12881
Domain	TF_AP-2	TFAP2A TFAP2B	1.02e-03	5	191	2	PF03299
Domain	-	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	1.05e-03	248	191	9	1.25.40.20
Domain	ANK	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	1.15e-03	251	191	9	SM00248
Domain	Ankyrin_rpt-contain_dom	ANKRD31 PPP1R12B TRPC6 ANKRD34B CASKIN2 PPP1R13B TEX14 KANK2 TANC1	1.24e-03	254	191	9	IPR020683
Domain	EPHD	KMT2C KMT2A KMT2D	1.40e-03	22	191	3	PS51805
Domain	SH3	MYO15B CASKIN2 ABI1 ARHGEF5 PPP1R13B SH3D19 MYO15A HCK	1.75e-03	216	191	8	SM00326
Domain	SH3	MYO15B CASKIN2 ABI1 ARHGEF5 PPP1R13B SH3D19 MYO15A HCK	1.75e-03	216	191	8	PS50002
Domain	SH3_2	MYO15B CASKIN2 ARHGEF5 SH3D19 MYO15A	1.89e-03	86	191	5	PF07653
Domain	SH3_2	MYO15B CASKIN2 ARHGEF5 SH3D19 MYO15A	1.89e-03	86	191	5	IPR011511
Domain	SH3_domain	MYO15B CASKIN2 ABI1 ARHGEF5 PPP1R13B SH3D19 MYO15A HCK	1.96e-03	220	191	8	IPR001452
Domain	Plakophilin/d_Catenin	PKP2 PKP4	2.11e-03	7	191	2	IPR028435
Domain	BTB	BTBD9 ZBTB21 ZBTB8A KLHL5 ZBTB3 SLX4	2.30e-03	131	191	6	PF00651
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KMT2C KMT2A BOD1L1 HCFC2 KMT2D	3.71e-05	42	128	5	M48018
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAPH1 GAB2 CDCA2 PTPN13 ALMS1 CASKIN2 STARD9 TBC1D1 ZBTB21 SEC16A PKP2 KMT2A BOD1L1 DCLK2 UVRAG SHROOM3 ABI1 ARHGEF5 LARP1B TESK1 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 TANC1 PATJ FGD6 PHLDB2 DOP1A AHNAK2 MTSS2	6.48e-18	861	200	33	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP DDN TNRC6B SYNPO ZNF318 BTBD9 ARHGEF11 ZBTB21 SEC16A SPATS2 BSN WNK2 PRRC2B SHROOM3 ABI1 ZEB1 HCN4 PKP4 ARHGEF12 KANK2 FAM171A1 AGO1 SH3D19 PDE4DIP TNS1 PHLDB2 MTSS2	1.27e-11	963	200	27	28671696
Pubmed	Human transcription factor protein interaction networks.	ATXN7L1 COPB2 MAML1 TNRC6B ZNF318 POGZ FLG2 CDCA2 KMT2C ALMS1 ZBTB21 SEC16A KMT2A HCFC2 HERC1 PRRC2B FOXL1 FLG XRN2 ZEB1 L3MBTL2 PPP1R13B REL KMT2D AGO1 DCP1B NCOA1 UNK ZFHX3 ELF4 N4BP1 SLX4	4.67e-11	1429	200	32	35140242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP UBE4B DDN TNRC6B POGZ PXDN STARD9 TBC1D1 SEC16A BOD1L1 PRRC2B ARHGEF12 BAZ2A MARK4 PDE4DIP GPCPD1 UBE3C	2.70e-10	407	200	17	12693553
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPH1 MED14 TNRC6B ZNF318 POGZ KMT2C PTPN13 ALMS1 SEC16A KMT2A BOD1L1 PRRC2B PPP1R13B ARHGAP35 TFAP2A KMT2D BAZ2A SH3D19 PATJ	5.47e-10	549	200	19	38280479
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	DAB2IP RAPH1 DAG1 CDKL5 CASKIN2 PKP2 SHROOM3 ABI1 PKP4 ARHGEF12 PPP1R13B SRCIN1 KANK2 DENND4C SH3D19 N4BP1 TANC1 PATJ PHLDB2	8.79e-10	565	200	19	25468996
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNRC6B PTPN13 ALMS1 SEC16A ARHGEF12 LARP1B ARHGAP35 KANK2 DENND4C DCP1B UNK TANC1	3.67e-09	209	200	12	36779422
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SAV1 TNRC6B PTPN13 ALMS1 TBC1D1 SEC16A PKP2 SHROOM3 LNX2 PKP4 PPP1R13B DENND4C CSNK1E UNK PATJ PHLDB2	8.05e-09	446	200	16	24255178
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DAB2IP RAPH1 SPEF2 WNK2 SRCIN1 ARHGAP35 UNK TANC1 FHDC1	8.29e-09	102	200	9	11214970
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	URI1 UBE4B RTEL1 ATXN7L1 TNRC6B SYNPO BTBD9 KMT2C EXD3 PTPN13 PXDN PTPRE PTPRG TBC1D1 BOD1L1 DCLK2 SPATS2 WNK2 SHROOM3 ZBTB8A SRCIN1 ARHGAP35 PCNX4 ZFHX3 TANC1 UBE3C CSMD1 PATJ DOP1A	9.69e-09	1489	200	29	28611215
Pubmed	Interaction network of human early embryonic transcription factors.	MAML1 POGZ FLG2 KMT2C ALMS1 SEC16A KMT2A PRRC2B ZEB1 L3MBTL2 KMT2D NCOA1 ZFHX3 SLX4	1.91e-08	351	200	14	38297188
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	TNRC6B ZNF318 PTPN13 ALMS1 CASKIN2 SEC16A PRRC2B PPP1R13B CSNK1E N4BP1 TANC1 AHNAK2	4.73e-08	263	200	12	34702444
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP NDOR1 UBE4B MAML1 MED14 ARHGEF11 KMT2C SEC16A HERC1 UVRAG WNK2 PRRC2B SHROOM3 LPAR5 ARHGAP35 TESK1 KMT2D PCNX4 MARK4 DEPDC5 TANC1 UBE3C AHNAK2	1.17e-07	1105	200	23	35748872
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2C KMT2A BOD1L1 HCFC2 KMT2D	1.45e-07	22	200	5	26886794
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2A KMT2D	1.87e-07	3	200	3	23932714
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DAB2IP COPB2 DAG1 ZNF318 KMT2C PTPN13 SEC16A BOD1L1 PLD1 HERC1 RAD17 AKAP6 DMTF1 ST6GAL1 ZNF496 CEP63 KLHL5 CSNK1E NFXL1 PATJ TNS1 SLX4	3.45e-07	1084	200	22	11544199
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	KMT2C KMT2A BOD1L1 HCFC2 UTY KMT2D	4.32e-07	50	200	6	37974198
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATXN7L1 TNRC6B ZNF318 POGZ ZNF469 ALMS1 ZBTB21 SEC16A PKP2 ZNF324 PLD1 PRRC2B PKP4 KANK2 BAZ2A NT5DC2 MARK4 ZFHX3 TANC1 TRAF3IP3 CSMD1 PHLDB2	5.61e-07	1116	200	22	31753913
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TNRC6B HCFC2 BSN PRRC2B PKP4 PPP1R13B SRCIN1 CBLB CEP63 UNK	6.07e-07	218	200	10	33378226
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2C KMT2A KMT2D	7.46e-07	4	200	3	23129768
Pubmed	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	KMT2C KMT2A KMT2D	7.46e-07	4	200	3	24081332
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPH1 TNRC6B ZNF318 POGZ PTPN13 ALMS1 ZBTB21 SEC16A ZEB1 L3MBTL2 DENND4C KMT2D ZFHX3	1.05e-06	418	200	13	34709266
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	CDX2 URI1 ZNF318 POGZ BTBD9 ZBTB21 ZNF324 UTY ZNF438 DMTF1 ZEB1 ZBTB8A ZNF496 TFAP2A BAZ2A NCOA1 UNK ZFHX3	1.16e-06	808	200	18	20412781
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MAML1 SAV1 TNRC6B ALMS1 SEC16A BOD1L1 L3MBTL2 KANK2 DENND4C DCP1B CSNK1E NFXL1 UNK N4BP1 TANC1 UBE3C PATJ	1.36e-06	733	200	17	34672954
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RAPH1 MAML1 TNRC6B ARHGEF11 ALMS1 TBC1D1 PRRC2B SHROOM3 L3MBTL2 PKP4 PPP1R13B KANK2 AGO1 IQCC CSNK1E UNK TANC1 UBE3C	2.48e-06	853	200	18	28718761
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPH1 UBE4B MED14 ZNF318 POGZ ZBTB21 SEC16A KMT2A XRN2 ZEB1 ARHGAP35 KMT2D BAZ2A CSNK1E UNK PHLDB2 CDH17	2.81e-06	774	200	17	15302935
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DAG1 TNRC6B PTPRG SPATS2 SHROOM3 LPAR5 PKP4 CEP63 AGO1 SH3D19 ZFHX3 TANC1 UBE3C NHEJ1	3.11e-06	536	200	14	15840001
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DAB2IP URI1 RAPH1 PPP1R12B COPB2 CDCA2 PTPN13 PTPRE PTPRG CASKIN2 SEC16A HERC1 PRRC2B PKP4 PPP1R13B TFAP2A FAM171A1 KMT2D TANC1 TNS1	3.12e-06	1049	200	20	27880917
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	RAPH1 DAG1 SYNPO CASKIN2 CBLB SH3D19 PHLDB2	3.20e-06	108	200	7	19531213
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DAG1 TNRC6B PTPRG SPATS2 SHROOM3 LPAR5 PKP4 CEP63 AGO1 SH3D19 ZFHX3 TANC1 UBE3C NHEJ1	3.25e-06	538	200	14	10512203
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	KMT2C ASCC2 UTY KMT2D	4.78e-06	20	200	4	19047629
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	MED14 POGZ KMT2C KMT2A BOD1L1 HCFC2 KMT2D	6.09e-06	119	200	7	23508102
Pubmed	Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers.	KMT2C KMT2A KMT2D	6.45e-06	7	200	3	36598580
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DAB2IP RTEL1 TNRC6B KMT2C ALMS1 TBC1D1 SEC16A AKAP6 ARHGAP35	6.83e-06	225	200	9	12168954
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	PPP1R12B SAV1 TNRC6B ZNF318 PTPN13 ASCC2 PKP2 SPATS2 PRRC2B COMMD5 KANK2 IQCC PDE4DIP UNK UBE3C PHLDB2	8.56e-06	754	200	16	33060197
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PPP1R12B COPB2 SYNPO ARHGEF11 CDKL5 SLC24A2 SEC16A KMT2A DCLK2 BSN WNK2 PRRC2B ABI1 PKP4 ARHGEF12 SRCIN1 ARHGAP35 KANK2 AGO1 PDE4DIP TANC1 TNS1 HCK	9.28e-06	1431	200	23	37142655
Pubmed	Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes.	SYNPO AKAP6 PDE4DIP	1.03e-05	8	200	3	17923693
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	KMT2C KMT2A KMT2D	1.03e-05	8	200	3	22266653
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2C KMT2A KMT2D	1.03e-05	8	200	3	23130995
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	URI1 RAPH1 NUTM2B HERC1 PRRC2B LNX2 LPAR5 L3MBTL2 CIR1 ZNF496 DENND4C NUTM2E ABHD5 AGO1 WFIKKN2 UNK TRAF3IP3 CSMD1 MYO15A SLX4 MTSS2	1.10e-05	1242	200	21	30973865
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	MAML1 TNRC6B ZNF318 FLG2 GAB2 CDCA2 CDKL5 PTPN13 SEC16A PKP2 PLD1 HCFC2 PRRC2B SHROOM3 MUC16 ZFHX3	1.24e-05	777	200	16	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAML1 SYNPO POGZ KMT2C CASKIN2 ZBTB21 BSN WNK2 AKAP6 SHROOM3 SRCIN1 UNK DEPDC5	1.35e-05	529	200	13	14621295
Pubmed	Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.	SAV1 DAG1 CSNK1E PATJ	1.44e-05	26	200	4	28720576
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	KMT2C KMT2A KMT2D	1.53e-05	9	200	3	22665483
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PPP1R12B MAML1 MED14 TNRC6B ZNF318 ARHGEF11 KMT2C PTPN13 PXDN ASCC2 KMT2A HCFC2 SPATS2 SHROOM3 ABI1 PKP4 ARHGEF12 KANK2 BAZ2A UNK ZFHX3 TANC1 PATJ	1.90e-05	1497	200	23	31527615
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	EED MAML1 POGZ ZNF587B CDCA2 KMT2C SEC16A ZEB1 KMT2D NCOA1 MYO15A	2.16e-05	398	200	11	35016035
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	COPB2 TNRC6B POGZ PTPN13 ASCC2 SPATS2 PRRC2B DDX60 LARP1B ARHGAP35 TFAP2A AGO1 NFXL1 UNK AHNAK2	2.17e-05	724	200	15	36232890
Pubmed	Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.	TNRC6B ALMS1 SEC16A CBLB SH3D19	2.53e-05	60	200	5	34761192
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	GAB2 ABI1 PKP4 HCK	2.59e-05	30	200	4	12522270
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	AKAP6 XRN2 PPP1R13B CEP63 ZNF10 PCNX4 PDE4DIP	2.87e-05	151	200	7	17043677
Pubmed	MLL3/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner.	CDX2 KMT2C KMT2D	2.99e-05	11	200	3	37012455
Pubmed	Endogenous retroviruses shape pluripotency specification in mouse embryos.	CDX2 URI1 NDOR1	2.99e-05	11	200	3	38266080
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ARHGEF11 ALMS1 SEC16A AKAP6 ARHGEF12 BAZ2A	3.19e-05	104	200	6	9205841
Pubmed	Conditional Deletion of AP-2α and AP-2β in the Developing Murine Retina Leads to Altered Amacrine Cell Mosaics and Disrupted Visual Function.	TFAP2A TFAP2B	3.29e-05	2	200	2	29715367
Pubmed	AP-2α/AP-2β Transcription Factors Are Key Regulators of Epidermal Homeostasis.	TFAP2A TFAP2B	3.29e-05	2	200	2	38237728
Pubmed	Agonist-induced Ca2+ sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study.	ARHGEF11 ARHGEF12	3.29e-05	2	200	2	24106280
Pubmed	Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.	ST6GAL1 MUC4	3.29e-05	2	200	2	30730306
Pubmed	CDH17+/CDX2+ Can be Helpful in Providing Support for Small Intestinal Origin Versus Pancreatic or Biliary Origin.	CDX2 CDH17	3.29e-05	2	200	2	33958523
Pubmed	Spatiotemporal gene targeting in the mouse corneal endothelium.	NDOR1 ZEB1	3.29e-05	2	200	2	37252171
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	3.29e-05	2	200	2	31924266
Pubmed	Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.	DAB2IP KMT2A	3.29e-05	2	200	2	14978793
Pubmed	LI-cadherin and CDX2: Useful Markers in Metastatic Gastrointestinal Adenocarcinoma Cells in Serous Cavity Effusion.	CDX2 CDH17	3.29e-05	2	200	2	30095466
Pubmed	ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).	KMT2A ABI1	3.29e-05	2	200	2	9694699
Pubmed	Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.	TFAP2A MUC4	3.29e-05	2	200	2	17621592
Pubmed	Developmental regulation of Eed complex composition governs a switch in global histone modification in brain.	EED KMT2A	3.29e-05	2	200	2	17259173
Pubmed	CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.	CDX2 CDH17	3.29e-05	2	200	2	20444732
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2A KMT2D	3.29e-05	2	200	2	26711341
Pubmed	Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.	RTEL1 PCDHGB6	3.29e-05	2	200	2	27485611
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	3.29e-05	2	200	2	28967912
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2A KMT2D	3.29e-05	2	200	2	24423662
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	3.29e-05	2	200	2	23544943
Pubmed	CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia.	CDX2 ST6GAL1	3.29e-05	2	200	2	25867765
Pubmed	Is t(10;11)(p11.2;q23) involving MLL and ABI-1 genes associated with congenital acute monocytic leukemia?	KMT2A ABI1	3.29e-05	2	200	2	12547160
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	3.29e-05	2	200	2	36601880
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	3.29e-05	2	200	2	28483418
Pubmed	Positive influence of AP-2alpha transcription factor on cadherin gene expression and differentiation of the ocular surface.	TFAP2A TFAP2B	3.29e-05	2	200	2	12694203
Pubmed	Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.	CDX2 CDH17	3.29e-05	2	200	2	22810971
Pubmed	Cloning and characterization of a second AP-2 transcription factor: AP-2 beta.	TFAP2A TFAP2B	3.29e-05	2	200	2	7555706
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	3.29e-05	2	200	2	34156443
Pubmed	Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas.	DMP1 DMTF1	3.29e-05	2	200	2	11711428
Pubmed	Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis.	TFAP2A TFAP2B	3.29e-05	2	200	2	8989526
Pubmed	Peptidoglycan recognition protein genes and risk of Parkinson's disease.	PGLYRP2 PGLYRP4	3.29e-05	2	200	2	24838182
Pubmed	Histone methylation regulates memory formation.	EED KMT2A	3.29e-05	2	200	2	20219993
Pubmed	A dual role for UVRAG in maintaining chromosomal stability independent of autophagy.	UVRAG CEP63	3.29e-05	2	200	2	22542840
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	3.29e-05	2	200	2	27280393
Pubmed	DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.	DAB2IP ZEB1	3.29e-05	2	200	2	25043300
Pubmed	Identification and characterization of RBM44 as a novel intercellular bridge protein.	RBM44 TEX14	3.29e-05	2	200	2	21364893
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	3.29e-05	2	200	2	36869380
Pubmed	Functional Divergence of Mammalian TFAP2a and TFAP2b Transcription Factors for Bidirectional Sleep Control.	TFAP2A TFAP2B	3.29e-05	2	200	2	32769099
Pubmed	A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.	CDX2 CDH17	3.29e-05	2	200	2	18353622
Pubmed	Inducible Knockout of Mouse Zfhx3 Emphasizes Its Key Role in Setting the Pace and Amplitude of the Adult Circadian Clock.	NDOR1 ZFHX3	3.29e-05	2	200	2	28816086
Pubmed	AP2 transcription factor induces apoptosis in retinoblastoma cells.	TFAP2A TFAP2B	3.29e-05	2	200	2	20607706
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	3.29e-05	2	200	2	25346535
Pubmed	Transcription factor-dependent 'anti-repressive' mammalian enhancers exclude H3K27me3 from extended genomic domains.	CDX2 EED	3.29e-05	2	200	2	29321178
Pubmed	Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.	FLG2 FLG	3.29e-05	2	200	2	24813994
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DAB2IP DAG1 PTPN13 SEC16A ABI1 PKP4 PPP1R13B CBLB FAM171A1 PHLDB2 MTSS2	3.61e-05	421	200	11	36976175
Pubmed	Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology.	ARHGEF11 KMT2A ARHGEF12	3.97e-05	12	200	3	12123608
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	KMT2C KMT2A KMT2D	3.97e-05	12	200	3	27563068
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MAML1 ZNF318 ALMS1 SEC16A BSN PRRC2B XRN2 PPP1R13B IQCC UNK TANC1 PATJ SLX4	4.02e-05	588	200	13	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	SVEP1 ZNF587B TBC1D1 ASCC2 PKP2 HERC1 DMTF1 PPP1R13B CBLB KMT2D DCP1B PDE4DIP ZBTB3	4.24e-05	591	200	13	15231748
Interaction	YWHAH interactions	DAB2IP SAV1 GAB2 CDCA2 PTPN13 ALMS1 CASKIN2 STARD9 TBC1D1 ZBTB21 SEC16A PKP2 KMT2A BOD1L1 DCLK2 HERC1 UVRAG WNK2 SHROOM3 ABI1 ARHGEF5 LARP1B TESK1 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 NCOA1 TANC1 PATJ FGD6 PHLDB2 DOP1A AHNAK2 MTSS2	2.65e-11	1102	195	37	int:YWHAH
Interaction	YWHAG interactions	DAB2IP EED RAPH1 SYNPO GAB2 CDCA2 PTPN13 ALMS1 CASKIN2 STARD9 TBC1D1 ZBTB21 SEC16A PKP2 KMT2A BOD1L1 DCLK2 UVRAG SHROOM3 ABI1 LNX2 ARHGEF5 LARP1B TESK1 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 UNK TANC1 PATJ FGD6 PHLDB2 DOP1A AHNAK2 MTSS2	2.33e-10	1248	195	38	int:YWHAG
Interaction	CGN interactions	DAB2IP EED SYNPO ARHGEF11 GAB2 PTPN13 TBC1D1 ZBTB21 PPP1R13B DENND4C DCP1B FGD6 PHLDB2	2.95e-09	152	195	13	int:CGN
Interaction	YWHAZ interactions	DAB2IP EED RAPH1 SAV1 SYNPO GAB2 PTPN13 ANKRD34B STARD9 TBC1D1 ZBTB21 PKP2 KMT2A UVRAG WNK2 SHROOM3 ABI1 LNX2 ARHGEF5 KANK2 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 UNK DEPDC5 TANC1 TNS1 FGD6 PHLDB2 MTSS2	4.46e-07	1319	195	33	int:YWHAZ
Interaction	EGR2 interactions	MAML1 POGZ FLG2 KMT2C SEC16A KMT2A PRRC2B KMT2D PDE4DIP NCOA1 ZFHX3	9.01e-07	171	195	11	int:EGR2
Interaction	YWHAB interactions	DAB2IP URI1 EED GAB2 PTPN13 STARD9 TBC1D1 ZBTB21 PKP2 KMT2A DCLK2 UVRAG SHROOM3 ARHGEF5 TESK1 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 UNK TANC1 FGD6 PHLDB2 AHNAK2 MTSS2	1.78e-06	1014	195	27	int:YWHAB
Interaction	CDH1 interactions	DAB2IP RAPH1 DAG1 CDKL5 PTPRG CASKIN2 PKP2 RAD17 SHROOM3 ABI1 ZEB1 PKP4 ARHGEF12 PPP1R13B SRCIN1 KANK2 DENND4C SH3D19 N4BP1 TANC1 PATJ PHLDB2	5.60e-06	768	195	22	int:CDH1
Interaction	OCLN interactions	DAB2IP PTPN13 PTPRG CASKIN2 PKP2 ABI1 PKP4 ARHGEF12 PPP1R13B KANK2 FAM171A1 CSNK1E SH3D19 TANC1 UBE3C PATJ PHLDB2	7.84e-06	500	195	17	int:OCLN
Interaction	GOLGA1 interactions	PTPN13 ALMS1 SEC16A ARHGEF12 PPP1R13B ARHGAP35 DENND4C UNK TANC1 AHNAK2	1.21e-05	183	195	10	int:GOLGA1
Interaction	SFN interactions	SAV1 GAB2 PTPN13 ALMS1 ZBTB21 PKP2 KMT2A SHROOM3 LNX2 ARHGEF5 TEX14 DENND4C FAM171A1 SH3D19 TANC1 FGD6 PHLDB2 DOP1A AHNAK2 MTSS2	1.35e-05	692	195	20	int:SFN
Interaction	CEP135 interactions	TNRC6B ALMS1 SEC16A PKP2 PLD1 PRRC2B SHROOM3 PPP1R13B CEP63 IQCC N4BP1 PHLDB2	1.44e-05	272	195	12	int:CEP135
Interaction	WWTR1 interactions	RAPH1 TNRC6B ZNF318 POGZ PTPN13 ALMS1 SEC16A KMT2A PRRC2B ZEB1 PPP1R13B TFAP2A KMT2D SH3D19 PATJ	1.63e-05	422	195	15	int:WWTR1
Interaction	AFDN interactions	EED TNRC6B CDKL5 PTPN13 ZBTB21 PKP2 KMT2A SHROOM3 PKP4 PPP1R13B FAM171A1 PATJ PHLDB2	2.30e-05	333	195	13	int:AFDN
Interaction	DPRX interactions	FLG2 SEC16A ZFHX3 SLX4	2.34e-05	18	195	4	int:DPRX
Interaction	LYN interactions	DAB2IP GAB2 PTPN13 PTPRG CASKIN2 PKP2 KMT2A PLD1 ABI1 ARHGEF5 PKP4 PPP1R13B KANK2 DENND4C FAM171A1 SH3D19 TANC1 HCK PHLDB2 AHNAK2	2.38e-05	720	195	20	int:LYN
Interaction	LATS2 interactions	SAV1 TNRC6B PTPN13 ALMS1 SEC16A LNX2 PKP4 PPP1R13B OXA1L UBE3C PATJ PHLDB2	2.62e-05	289	195	12	int:LATS2
Interaction	KCTD3 interactions	GAB2 PTPN13 TBC1D1 ZBTB21 DENND4C DCP1B NCOA1 FGD6 PHLDB2	3.22e-05	164	195	9	int:KCTD3
Interaction	GARRE1 interactions	TNRC6B ALMS1 SEC16A PRRC2B KANK2 AGO1 DCP1B IQCC UNK	3.71e-05	167	195	9	int:GARRE1
Interaction	GSK3A interactions	TTC16 TNRC6B ARHGEF11 PTPN13 ALMS1 SEC16A ARHGEF12 LARP1B ARHGAP35 KANK2 DENND4C DCP1B UNK TANC1 SLX4	4.85e-05	464	195	15	int:GSK3A
Interaction	FLOT1 interactions	EED SYNPO PTPN13 CASKIN2 PKP2 BOD1L1 PKP4 ARHGEF12 PPP1R13B KANK2 FAM171A1 ELF4 TANC1 PATJ PHLDB2	6.32e-05	475	195	15	int:FLOT1
Interaction	MYO15B interactions	C7orf57 GAB2 MYO15B ZNF438 ZBTB8A REL ZBTB3	6.45e-05	103	195	7	int:MYO15B
Interaction	EPB41L4A interactions	PTPN13 PKP2 PKP4 PPP1R13B KANK2 FAM171A1 PATJ PHLDB2	6.69e-05	140	195	8	int:EPB41L4A
Interaction	CBY1 interactions	DAB2IP GAB2 PTPN13 TBC1D1 ZBTB21 DENND4C DCP1B FGD6 PHLDB2	7.24e-05	182	195	9	int:CBY1
Interaction	KIF13B interactions	GAB2 PTPN13 TBC1D1 ZBTB21 DENND4C DCP1B FGD6 PHLDB2	7.39e-05	142	195	8	int:KIF13B
Interaction	RNF43 interactions	URI1 TNRC6B ZNF318 PTPN13 ALMS1 CASKIN2 SEC16A PRRC2B PPP1R13B CSNK1E NFXL1 N4BP1 TANC1 AHNAK2	7.49e-05	427	195	14	int:RNF43
Interaction	YWHAE interactions	DAB2IP SAV1 GAB2 PTPN13 TBC1D1 ZBTB21 PKP2 KMT2A DCLK2 UVRAG WNK2 SHROOM3 ABI1 ARHGEF5 SRCIN1 KANK2 DENND4C FAM171A1 DCP1B CSNK1E SH3D19 MARK4 UNK DEPDC5 TANC1 FGD6 PHLDB2	8.10e-05	1256	195	27	int:YWHAE
Interaction	TNRC6A interactions	MED14 SAV1 TNRC6B KMT2C SEC16A PRRC2B KANK2 AGO1 DCP1B UNK AHNAK2	9.35e-05	280	195	11	int:TNRC6A
Interaction	MAGI1 interactions	DDN DAG1 SYNPO GAB2 ZBTB21 TFAP2A DENND4C PHLDB2	9.42e-05	147	195	8	int:MAGI1
Interaction	TNRC6B interactions	SAV1 TNRC6B ALMS1 SEC16A PRRC2B KANK2 CEP63 AGO1 DCP1B IQCC UNK	9.95e-05	282	195	11	int:TNRC6B
Interaction	C7orf57 interactions	NDOR1 C7orf57 MYO15B	1.02e-04	10	195	3	int:C7orf57
Interaction	ZNRD2 interactions	UBE4B RTEL1 MYO15B ZBTB21 SPATS2 RAD17 ARHGEF5 PPP1R13B ARHGAP35 TANC1 TRAF3IP3	1.20e-04	288	195	11	int:ZNRD2
Interaction	KLF5 interactions	CDX2 MAML1 FLG2 KMT2C SEC16A PRRC2B FLG XRN2 KMT2D	1.23e-04	195	195	9	int:KLF5
Interaction	PFN1 interactions	EED RAPH1 ARHGEF11 ALMS1 SEC16A BOD1L1 ABI1 ARHGEF12 ARHGAP35 DENND4C DCP1B SH3D19 TANC1 AHNAK2 MTSS2	1.36e-04	509	195	15	int:PFN1
Interaction	VASP interactions	RAPH1 TNRC6B ALMS1 SEC16A SHROOM3 ABI1 ARHGEF12 PPP1R13B ARHGAP35 KANK2 PATJ	1.44e-04	294	195	11	int:VASP
Interaction	PIBF1 interactions	SAV1 TNRC6B C7orf57 PKP2 ZNF438 LARP1B KANK2 CEP63 ZFHX3	1.49e-04	200	195	9	int:PIBF1
Interaction	FTL interactions	EED POGZ ALMS1 PLD1 PIPSL L3MBTL2 ARHGEF5 ARHGAP35 ABCB10 CSNK1E MARK4 PHLDB2	1.54e-04	348	195	12	int:FTL
Interaction	ARL16 interactions	TNRC6B ZNF318 CDCA2 PRRC2B SHROOM3 REL	1.55e-04	83	195	6	int:ARL16
Interaction	FEV interactions	MAML1 POGZ KMT2C KMT2A PRRC2B ZEB1 L3MBTL2 KMT2D ZFHX3	1.66e-04	203	195	9	int:FEV
Interaction	ZBTB21 interactions	GAB2 PTPN13 TBC1D1 ZBTB21 DENND4C FGD6 SLX4 PHLDB2	1.77e-04	161	195	8	int:ZBTB21
Interaction	TRIM66 interactions	ZNF318 ALMS1 SEC16A PKP2 PRRC2B PKP4 NT5DC2 MARK4 CSMD1	1.79e-04	205	195	9	int:TRIM66
Interaction	PIPSL interactions	POGZ ALMS1 PLD1 PIPSL L3MBTL2 DENND4C ABCB10 CSNK1E MARK4 PHLDB2	1.79e-04	252	195	10	int:PIPSL
Interaction	CRX interactions	MAML1 POGZ KMT2C MYO15B PRRC2B L3MBTL2 KANK2 KMT2D NCOA1 ZFHX3	1.91e-04	254	195	10	int:CRX
Interaction	TOP3B interactions	DAB2IP NDOR1 UBE4B RTEL1 MAML1 MED14 TNRC6B ARHGEF11 KMT2C SEC16A PKP2 HERC1 UVRAG WNK2 PRRC2B FOXL1 SHROOM3 LPAR5 ARHGAP35 KANK2 TESK1 KMT2D PCNX4 MARK4 UNK DEPDC5 TANC1 UBE3C AHNAK2	1.92e-04	1470	195	29	int:TOP3B
Interaction	YWHAQ interactions	DAB2IP GAB2 PTPN13 STARD9 TBC1D1 ZBTB21 PKP2 KMT2A DCLK2 UVRAG SHROOM3 ABI1 ARHGEF5 LARP1B DENND4C FAM171A1 CSNK1E SH3D19 NCOA1 TANC1 FGD6 PHLDB2 DOP1A MTSS2	2.13e-04	1118	195	24	int:YWHAQ
Interaction	NHLH1 interactions	CDCA2 ZBTB21 KMT2A ZEB1 L3MBTL2 KMT2D	2.13e-04	88	195	6	int:NHLH1
Interaction	ZDHHC15 interactions	RTEL1 ZNF318 ADCYAP1R1 SHROOM3 NFXL1 UNK CERCAM	2.17e-04	125	195	7	int:ZDHHC15
Interaction	DCP1A interactions	RAPH1 TNRC6B ALMS1 ZBTB21 SEC16A KANK2 AGO1 DCP1B	2.18e-04	166	195	8	int:DCP1A
Interaction	CEP85 interactions	SAV1 TNRC6B ALMS1 SEC16A PRRC2B CEP63 AGO1 UNK	2.46e-04	169	195	8	int:CEP85
Interaction	KMT2D interactions	KMT2C KMT2A BOD1L1 HCFC2 UTY FOXL1 KMT2D ELF4	2.46e-04	169	195	8	int:KMT2D
Interaction	SH3KBP1 interactions	RAPH1 DDN DAG1 SYNPO CDKL5 CASKIN2 CBLB SH3D19 PATJ HCK PHLDB2	2.61e-04	315	195	11	int:SH3KBP1
Interaction	MAST3 interactions	SAV1 GAB2 PTPN13 ZBTB21 PKP2 DENND4C PHLDB2	2.64e-04	129	195	7	int:MAST3
Interaction	SIPA1L1 interactions	EED SYNPO GAB2 PTPN13 ZBTB21 DENND4C CEP63 PHLDB2	3.00e-04	174	195	8	int:SIPA1L1
Interaction	KSR1 interactions	GAB2 PTPN13 TBC1D1 ZBTB21 DENND4C FGD6 PHLDB2	3.03e-04	132	195	7	int:KSR1
Interaction	TRIM52 interactions	URI1 RTEL1 ZNF318 ALMS1 ZNF324 L3MBTL2 TANC1	3.18e-04	133	195	7	int:TRIM52
Interaction	KMT2C interactions	KMT2C KMT2A BOD1L1 HCFC2 UTY FOXL1 KMT2D	3.32e-04	134	195	7	int:KMT2C
Interaction	PTPN14 interactions	CDX2 EED SAV1 PTPN13 PTPRE PTPRG ZBTB21 DENND4C	3.36e-04	177	195	8	int:PTPN14
Interaction	ZFP36 interactions	TNRC6B SEC16A PRRC2B L3MBTL2 PPP1R13B KANK2 AGO1 DCP1B	3.91e-04	181	195	8	int:ZFP36
Interaction	SSX3 interactions	ARHGEF12 ZNF496 CEP63 ZBTB3	3.93e-04	36	195	4	int:SSX3
Interaction	YAP1 interactions	COPB2 MED14 SAV1 DDN TNRC6B ZNF318 POGZ FLG2 KMT2C PTPN13 SEC16A KMT2A BOD1L1 UVRAG XRN2 ZEB1 ARHGAP35 KMT2D BAZ2A CSNK1E SH3D19 UNK PATJ	3.94e-04	1095	195	23	int:YAP1
Interaction	NUP43 interactions	TNRC6B ZNF318 POGZ CDCA2 KMT2A BOD1L1 HCFC2 XRN2 L3MBTL2 DDX60 KMT2D BAZ2A ZFHX3 ELF4 SLX4 AHNAK2	3.97e-04	625	195	16	int:NUP43
Interaction	SYNE3 interactions	TNRC6B ZNF318 ALMS1 SEC16A PKP2 PRRC2B SHROOM3 PPP1R13B KANK2 CEP63 DCP1B IQCC UNK	4.05e-04	444	195	13	int:SYNE3
Cytoband	4q31.3	DCLK2 SH3D19 FHDC1	3.35e-04	31	200	3	4q31.3
Cytoband	3p21	DAG1 CCRL2 ABHD5	4.04e-04	33	200	3	3p21
Cytoband	19q13.3	PTGIR ARHGAP35 CD33 MARK4	4.69e-04	82	200	4	19q13.3
Cytoband	10p11.2	ABI1 ZEB1	5.20e-04	8	200	2	10p11.2
Cytoband	12q13.12	DDN SPATS2 KMT2D	6.14e-04	38	200	3	12q13.12
GeneFamily	PDZ domain containing	ARHGEF11 SHROOM4 PTPN13 SHROOM3 LNX2 ARHGEF12 PATJ AHNAK2	1.13e-05	152	126	8	1220
GeneFamily	Myosins, class XV\|Deafness associated genes\|FERM domain containing	MYO15B MYO15A	4.82e-05	2	126	2	1105
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	BTBD9 ZBTB21 ZBTB8A KLHL5 ZBTB3 SLX4	3.53e-04	134	126	6	861
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG2 FLG	9.89e-04	7	126	2	1350
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF11 ARHGEF5 ARHGEF12 FGD6	1.16e-03	66	126	4	722
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF318 ZNF587B ZNF469 ZBTB21 ZNF324 ZNF438 ZEB1 ZBTB8A ZNF496 ZNF10 ZNF814 ZFHX3 ZBTB3	1.51e-03	718	126	13	28
GeneFamily	Ankyrin repeat domain containing	ANKRD31 PPP1R12B ANKRD34B CASKIN2 PPP1R13B KANK2 TANC1	1.55e-03	242	126	7	403
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2C KMT2A KMT2D	1.69e-03	34	126	3	487
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	URI1 PPP1R12B CDCA2 PPP1R13B CSMD1 TNS1	1.69e-03	181	126	6	694
GeneFamily	PHD finger proteins	KMT2C KMT2A KMT2D BAZ2A	3.62e-03	90	126	4	88
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 ZFHX3	4.77e-03	15	126	2	529
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	PTPN13 MYO15B MYO15A	5.10e-03	50	126	3	1293
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	DAG1 KMT2A PRRC2B SRCIN1 TFAP2A TFAP2B KMT2D AGO1 SH3D19 TANC1	2.99e-06	199	198	10	M7319
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	UBE4B SEC16A UVRAG ST6GAL1 NFXL1 NCOA1 ZFHX3 DEPDC5 TANC1	1.02e-05	181	198	9	M8662
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP	SAV1 CILP2 PTPN13 TBC1D1 CCRL2 REL N4BP1 PATJ FGD6	2.18e-05	199	198	9	M6895
Coexpression	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	SAV1 ZNF318 UVRAG RAD17 ARHGEF12 REL DENND4C OXA1L NCOA1	2.18e-05	199	198	9	M5799
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	PPP1R12B PTPRG TBC1D1 AKAP6 ZEB1 CBLB ZFHX3 TNS1	2.45e-05	155	198	8	M39246
Coexpression	MILI_PSEUDOPODIA	GAB2 ZEB1 PKP4 KANK2 PHLDB2	3.08e-05	48	198	5	M17507
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RAPH1 NUTM2A ZNF318 SLC24A2 BOD1L1 DCLK2 HCFC2 HERC1 BSN PRRC2B AKAP6 GPR26 VSTM2A ARHGEF12 SRCIN1 LARP1B ARHGAP35 PDE4DIP ZFHX3 CSMD1 DOP1A AHNAK2	3.52e-05	1106	198	22	M39071
Coexpression	MILI_PSEUDOPODIA	GAB2 ZEB1 PKP4 KANK2 PHLDB2	4.14e-05	51	198	5	MM824
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	RAPH1 PTPRG TBC1D1 HERC1 CBLB SH3D19 NCOA1 TNS1	6.31e-05	177	198	8	M39245
Coexpression	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP	MAML1 PTPN13 BOD1L1 PRRC2B RAD17 PKP4 ZBTB8A CDH17	6.56e-05	178	198	8	M8996
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	MED14 DAG1 PTPN13 PXDN PTPRE PTPRG PKP2 PLD1 SPATS2 UTY SHROOM3 CYP26B1 DRP2 ARHGEF5 REL ST6GAL1 IFNAR2 NFXL1 ELF4 PATJ PHLDB2 MTSS2	8.13e-06	837	193	22	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	URI1 RAPH1 MED14 SAV1 ADCYAP1R1 BOD1L1 DMTF1 XRN2 ZEB1 PKP4 CIR1 ARHGEF12 ARHGAP35 KLHL5 DEPDC5 N4BP1 MTSS2	3.27e-05	595	193	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	NDOR1 ZNF587B ZNF324 ZEB1 PPP1R13B ZNF10 NCOA1 UNK DOP1A	5.09e-08	162	199	9	22b2a32217d357146c117e618813d451510a1801
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC24A2 HERC1 BSN HCN4 PKP4 DENND4C PDE4DIP MUC4 DOP1A	9.41e-08	174	199	9	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TNRC6B BTBD9 KMT2C KMT2A HERC1 REL CBLB ZNF10 GPCPD1	1.82e-07	188	199	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEF2 SHROOM4 PTPRG CASKIN2 DCLK2 ZEB1 PKP4 FAM171A1 SH3D19	2.37e-07	194	199	9	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C SLC24A2 SEC16A KMT2A BOD1L1 HERC1 UTY NCOA1 PHLDB2	2.48e-07	195	199	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C SLC24A2 SEC16A KMT2A BOD1L1 HERC1 UTY NCOA1 PHLDB2	2.48e-07	195	199	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRE PTPRG CASKIN2 SLC24A2 ZEB1 CYP26B1 ST6GAL1 FAM171A1 MARK4	2.59e-07	196	199	9	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRE PTPRG CASKIN2 SLC24A2 ZEB1 CYP26B1 ST6GAL1 FAM171A1 MARK4	2.59e-07	196	199	9	473980c827443464d08a0be28c53e3536369b12a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRE PTPRG CASKIN2 SLC24A2 ZEB1 CYP26B1 ST6GAL1 FAM171A1 MARK4	2.59e-07	196	199	9	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	SPEF2 PTPRG DCLK2 ZEB1 PKP4 ARHGEF12 FAM171A1 KLHL5 GPCPD1	3.07e-07	200	199	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPEF2 KMT2C PTPRG KMT2A ZEB1 PKP4 ARHGEF12 FAM171A1 FGD6	3.07e-07	200	199	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RAPH1 PTGIR CEACAM21 LILRB5 SRCIN1 ZNF496 IQCC CERCAM	7.02e-07	162	199	8	64353d33af0e82ebb7cf2bba74d52ca0586a58fc
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	TRPC6 BSN CYP26B1 GPR26 FAM135B RTL1 CERCAM TMEM26	8.44e-07	166	199	8	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	PPP1R12B TNRC6B CASKIN2 KMT2A HERC1 AKAP6 FAM171A1 MTSS2	1.37e-06	177	199	8	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC24A2 HERC1 BSN HCN4 DENND4C RTL1 PDE4DIP MUC4	1.43e-06	178	199	8	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	PTPN13 PTPRG SHROOM3 LNX2 FHDC1 PATJ MUCL3 LRRC36	1.75e-06	183	199	8	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPC6 PTGIR PTPRG WNK2 ADARB2-AS1 NT5DC2 ZFHX3 TNS1	2.06e-06	187	199	8	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	PTPN13 PTPRG SHROOM3 LNX2 TANC1 FHDC1 MUCL3 LRRC36	2.15e-06	188	199	8	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	IPF-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	SYNPO SHROOM4 PXDN CASKIN2 ZEB1 ARHGEF12 TANC1 TMEM26	2.23e-06	189	199	8	ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTGIR TBC1D1 WNK2 FOXL1 AKAP6 KANK2 ZFHX3 CSMD1	2.23e-06	189	199	8	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTGIR TBC1D1 WNK2 FOXL1 AKAP6 KANK2 ZFHX3 CSMD1	2.23e-06	189	199	8	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	IPF-Endothelial-VE_Capillary_A\|IPF / Disease state, Lineage and Cell class	SYNPO SHROOM4 PXDN CASKIN2 ZEB1 ARHGEF12 TANC1 TMEM26	2.32e-06	190	199	8	b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PXDN CASKIN2 STARD9 ZEB1 ARHGEF12 KLHL5 TANC1 TMEM26	2.32e-06	190	199	8	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	SHROOM4 PXDN PTPRG CASKIN2 ZEB1 ARHGEF12 SH3D19 TANC1	2.41e-06	191	199	8	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 SHROOM4 SHROOM3 LNX2 PPP1R13B ST6GAL1 ABCC6 PATJ	2.41e-06	191	199	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	BTBD9 KMT2C KMT2A HERC1 UTY CBLB ZNF10 GPCPD1	2.51e-06	192	199	8	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 CDKL5 SHROOM3 LNX2 PPP1R13B ST6GAL1 ABCC6 PATJ	2.51e-06	192	199	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PXDN PTPRG CYP26B1 ARHGEF12 PPP1R13B FAM171A1 KLHL5 PHLDB2	2.51e-06	192	199	8	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP TANC1 PATJ	2.51e-06	192	199	8	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	COVID-19-COVID-19_Mild-Others-RBC\|COVID-19_Mild / Disease, condition lineage and cell class	EFCAB5 NUTM2A PTPRG ASCC2 ARHGEF12 KANK2 FHDC1 TNS1	3.04e-06	197	199	8	3bae601e5d9689ea57e923814af8cdcae690becc
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	DAB2IP SYNPO PXDN SHROOM3 KANK2 PATJ TNS1 PHLDB2	3.15e-06	198	199	8	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 GAB2 PTPN13 PTPRG STARD9 ZEB1 KANK2 PHLDB2	3.27e-06	199	199	8	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RAPH1 PTGIR CEACAM21 LILRB5 SRCIN1 IQCC CERCAM	8.86e-06	163	199	7	9f5facfa1864eb63e2f8022ad7379d9252b7a254
ToppCell	Ionocyte-iono-3\|World / Class top	RTEL1 ZNF318 CDCA2 RNF145 UTY LARP1B XKR5	9.98e-06	166	199	7	9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	PTPRE SHROOM3 ARHGEF12 TANC1 PATJ TNS1 PHLDB2	1.17e-05	170	199	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R12B MAML1 WNK2 PRRC2B TESK1 TMEM26 XKR5	1.31e-05	173	199	7	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R12B MAML1 WNK2 PRRC2B TESK1 TMEM26 XKR5	1.31e-05	173	199	7	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EED SYNPO BOD1L1 UTY LPAR5 ST6GAL1 CBLB	1.35e-05	174	199	7	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	HCN4 FREM3 ZFHX3 FHDC1 PATJ AHNAK2	1.38e-05	116	199	6	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO CDKL5 PXDN PPP1R13B NT5DC2 FHDC1 PHLDB2	1.41e-05	175	199	7	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPN13 RNF145 WNK2 SHROOM3 TEX14 PATJ MUC4	1.69e-05	180	199	7	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM4 PTPRE SHROOM3 PPP1R13B ST6GAL1 PATJ MUC4	1.75e-05	181	199	7	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	BTBD9 PTPN13 PTPRE RNF145 SHROOM3 PATJ MUC4	1.75e-05	181	199	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	PXDN CASKIN2 STARD9 DCLK2 CCDC116 ZEB1 TMEM26	1.81e-05	182	199	7	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	wk_08-11-Epithelial-PNS-PCP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GAB2 CILP2 DCLK2 HCN4 VSTM2A SRCIN1 TFAP2B	1.94e-05	184	199	7	eac2a9089913f33a961ba11519b53645790f2056
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KMT2C PTPRE MUC16 REL NFXL1 ZFHX3 CSMD1	2.08e-05	186	199	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.16e-05	187	199	7	17a37fc3a1d62fef3137e5ff26a84c0b8c80e124
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.16e-05	187	199	7	1b0eb29394040555516677b9de75c15e769c4c53
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	SHROOM4 PXDN CASKIN2 ZEB1 ARHGEF12 TANC1 TMEM26	2.16e-05	187	199	7	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.16e-05	187	199	7	11c773cf3dc1e725b7e4d8edd676c8a94a231d2a
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.16e-05	187	199	7	5ce7cf02990465b6f793205e4be07e8337b3570a
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	PPP1R12B TBC1D1 WNK2 AKAP6 PPP1R13B PDE4DIP TANC1	2.23e-05	188	199	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.31e-05	189	199	7	7ac78441a15a82218deaafd47accff2ea5c8de20
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.31e-05	189	199	7	389ccb68acb82893709f256315111470cf4beed3
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM4 PXDN CASKIN2 ZEB1 KLHL5 TANC1 TMEM26	2.31e-05	189	199	7	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP PATJ	2.31e-05	189	199	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMIGD3 CEACAM21 LPAR5 ST6GAL1 ZFHX3 TRAF3IP3 HCK	2.31e-05	189	199	7	58465b9407fbce91cca8f199950d6e0054c38fbc
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	TRPC6 ADCYAP1R1 STARD9 DCLK2 ZEB1 ADARB2-AS1 TANC1	2.31e-05	189	199	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM4 PXDN CASKIN2 DCLK2 ZEB1 TANC1 TMEM26	2.39e-05	190	199	7	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP PATJ	2.39e-05	190	199	7	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP PATJ	2.39e-05	190	199	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRE SLC24A2 STARD9 ZEB1 ST6GAL1 KLHL5 MARK4	2.47e-05	191	199	7	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPN13 PTPRG SHROOM3 PPP1R13B FHDC1 PATJ LRRC36	2.47e-05	191	199	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCLK2 ARHGEF5 SRCIN1 ZFHX3 FHDC1 CSMD1 HCK	2.47e-05	191	199	7	54f07e4de61735051498846afb44b1798bed8144
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPN13 RNF145 SHROOM3 LNX2 PPP1R13B PATJ LRRC36	2.47e-05	191	199	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP PATJ	2.47e-05	191	199	7	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP TANC1	2.47e-05	191	199	7	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PXDN CASKIN2 STARD9 ZEB1 ARHGEF12 TANC1 TMEM26	2.47e-05	191	199	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	PTPN13 PTPRG SHROOM3 ARHGEF12 TANC1 FHDC1 PATJ	2.55e-05	192	199	7	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	BTBD9 PTPN13 SHROOM3 LNX2 PPP1R13B ABCC6 PATJ	2.55e-05	192	199	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDKL5 PTPN13 PTPRG SHROOM3 LNX2 FHDC1 MUCL3	2.55e-05	192	199	7	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ATXN7L1 TNRC6B BTBD9 PTPRG SHROOM3 SH3D19 PATJ	2.55e-05	192	199	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CASKIN2 ZEB1 DDX60 ARHGEF12 FAM171A1 TANC1 LRRC36	2.55e-05	192	199	7	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	PTPN13 PTPRG SHROOM3 PPP1R13B FHDC1 PATJ LRRC36	2.55e-05	192	199	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	PTPN13 SHROOM3 LNX2 PPP1R13B ABCC6 TANC1 PATJ	2.55e-05	192	199	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	IPF-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	SHROOM4 PXDN PTPRG CASKIN2 ZEB1 ARHGEF12 TANC1	2.64e-05	193	199	7	d7750a7575ef257963b7f1c64fa67c52dbff797b
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEF2 SHROOM4 IFNAR2 FAM171A1 SH3D19 GPCPD1 LRRC36	2.64e-05	193	199	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEF2 SHROOM4 DCLK2 ZEB1 PKP4 FAM171A1 LRRC36	2.64e-05	193	199	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 CASKIN2 ZEB1 PKP4 ARHGEF12 FAM171A1 LRRC36	2.64e-05	193	199	7	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 CASKIN2 ZEB1 PKP4 ARHGEF12 FAM171A1 LRRC36	2.64e-05	193	199	7	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 SHROOM4 PTPN13 SHROOM3 PPP1R13B ABCC6 PATJ	2.64e-05	193	199	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PXDN PTPRG CYP26B1 ARHGEF12 PPP1R13B KLHL5 PHLDB2	2.73e-05	194	199	7	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 CASKIN2 ZEB1 PKP4 ARHGEF12 FAM171A1 TANC1	2.73e-05	194	199	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 CASKIN2 ZEB1 PKP4 ARHGEF12 FAM171A1 TANC1	2.73e-05	194	199	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPN13 PTPRG RNF145 SHROOM3 PPP1R13B FHDC1 PATJ	2.73e-05	194	199	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	PPP1R12B PKP2 WNK2 AKAP6 PPP1R13B PDE4DIP TANC1	2.73e-05	194	199	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEF2 SHROOM4 PTPRG ZEB1 PKP4 ARHGEF12 FAM171A1	2.73e-05	194	199	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	SVEP1 GAB2 PTPRG ZEB1 CBLB NCOA1 ZFHX3	2.82e-05	195	199	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SHROOM4 PXDN STARD9 ZEB1 ARHGEF12 KLHL5 TMEM26	2.91e-05	196	199	7	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Severe-Plasmablast\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COPB2 SPATS2 ST6GAL1 LARP1B MEI1 IFNAR2 NT5DC2	3.01e-05	197	199	7	1089aa7991812378668d0f3d57f8000e6245a713
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R12B TBC1D1 AKAP6 KANK2 ZFHX3 TNS1 PHLDB2	3.01e-05	197	199	7	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPH1 TRPC6 BTBD9 STARD9 KANK2 TFAP2A RTL1	3.01e-05	197	199	7	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	RAPH1 PTGIR DCLK2 LILRB5 FHDC1 FGD6 HCK	3.01e-05	197	199	7	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	RAPH1 PTGIR DCLK2 LILRB5 FHDC1 FGD6 HCK	3.01e-05	197	199	7	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R12B PTGIR AKAP6 KANK2 ZFHX3 TNS1 PHLDB2	3.01e-05	197	199	7	68c23c23b6924892f4c238cf2f5abc7927e04fbc
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPN13 PTPRG RNF145 SHROOM3 PPP1R13B FHDC1 LRRC36	3.11e-05	198	199	7	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	EFCAB5 SEC16A HERC1 DDX60 BRME1 N4BP1 TANC1	3.11e-05	198	199	7	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	BTBD9 GAB2 PTPN13 PTPRG SHROOM3 NCOA1 TANC1	3.11e-05	198	199	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKP2 WNK2 PGLYRP4 MUC16 TFAP2A KLHL5 MUC4	3.11e-05	198	199	7	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DAB2IP SYNPO PXDN KANK2 N4BP1 TNS1 PHLDB2	3.11e-05	198	199	7	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; PC3; HT_HG-U133A	RTEL1 MED14 ALMS1 CASKIN2 PRRC2B PKP4 CIR1 ARHGEF12 TESK1 CEP63 BAZ2A ZFHX3	1.58e-07	199	195	12	5859_DN
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	4.43e-05	2	197	2	DOID:0080598 (implicated_via_orthology)
Disease	Paroxysmal atrial fibrillation	UBE4B PKP2 HERC1 AKAP6 HCN4 ZFHX3 PHLDB2	8.94e-05	156	197	7	C0235480
Disease	familial atrial fibrillation	UBE4B PKP2 HERC1 AKAP6 HCN4 ZFHX3 PHLDB2	8.94e-05	156	197	7	C3468561
Disease	Persistent atrial fibrillation	UBE4B PKP2 HERC1 AKAP6 HCN4 ZFHX3 PHLDB2	8.94e-05	156	197	7	C2585653
Disease	Atrial Fibrillation	UBE4B PKP2 HERC1 AKAP6 HCN4 ZFHX3 PHLDB2	1.05e-04	160	197	7	C0004238
Disease	Kabuki syndrome (implicated_via_orthology)	UTY KMT2D	1.32e-04	3	197	2	DOID:0060473 (implicated_via_orthology)
Disease	atrial fibrillation	UBE4B SLC24A2 PKP2 HCFC2 HERC1 AKAP6 HCN4 MEI1 ZFHX3 PHLDB2	2.11e-04	371	197	10	EFO_0000275
Disease	Clinodactyly	TFAP2A TFAP2B	2.64e-04	4	197	2	C4551485
Disease	Clinodactyly of fingers	TFAP2A TFAP2B	2.64e-04	4	197	2	C0265610
Disease	Neurodevelopmental Disorders	TNRC6B POGZ CDKL5 KMT2C KMT2A	4.07e-04	93	197	5	C1535926
Disease	coronary artery disease	DAB2IP ANKRD31 PPP1R12B SVEP1 DCLK2 BSN WNK2 FOXL1 SHROOM3 ZEB1 HCN4 ARHGEF12 KANK2 TFAP2B ABHD5 MARK4 TNS1 FGD6 CDH17	4.33e-04	1194	197	19	EFO_0001645
Disease	Weaver syndrome	EED KMT2A	4.38e-04	5	197	2	C0265210
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC4	4.38e-04	5	197	2	DOID:3030 (is_marker_for)
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	4.38e-04	5	197	2	C0206630
Disease	adenoid cystic carcinoma (is_implicated_in)	KMT2C XRN2	4.38e-04	5	197	2	DOID:0080202 (is_implicated_in)
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	6.54e-04	6	197	2	C0334488
Disease	age at menarche	TRPC6 DDN DAG1 GAB2 ALMS1 PTPRG BSN TFAP2B RTL1 NT5DC2 CSMD1 SLX4	6.92e-04	594	197	12	EFO_0004703
Disease	Sezary Syndrome	KMT2C ZEB1 KMT2D	7.62e-04	27	197	3	C0036920
Disease	Malignant neoplasm of breast	RAPH1 PPP1R12B MED14 ZNF318 BOD1L1 AKAP6 ZNF438 ZEB1 PCDHGB6 TESK1 TFAP2A KMT2D ABCB10 NCOA1 ZBTB3 TNS1 DOP1A	9.22e-04	1074	197	17	C0006142
Disease	anthropometric measurement	ZNF469 DMP1 BSN FOXL1 DMTF1 NHEJ1	9.57e-04	168	197	6	EFO_0004302
Disease	resting heart rate, chronic obstructive pulmonary disease	GAB2 HERC1 TNS1	1.04e-03	30	197	3	EFO_0000341, EFO_0004351
Disease	Leukemia, Myelocytic, Acute	KMT2C PXDN KMT2A CBLB CD33 SLX4	1.11e-03	173	197	6	C0023467
Disease	calcium measurement	ANKRD31 ATXN7L1 ZNF318 GAB2 CILP2 CASKIN2 ABCC6 PCNX4 NT5DC2 MARK4 GPCPD1 ZFHX3	1.12e-03	628	197	12	EFO_0004838
Disease	congenital heart disease (implicated_via_orthology)	KMT2C KMT2A HCFC2 KMT2D	1.19e-03	69	197	4	DOID:1682 (implicated_via_orthology)
Disease	HOMA-IR	SPEF2 COPB2 CSMD1	1.38e-03	33	197	3	EFO_0004501
Disease	lung cancer (is_implicated_in)	DAB2IP RTEL1 CCDC116 XRN2	1.54e-03	74	197	4	DOID:1324 (is_implicated_in)
Disease	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	TRPC6 SYNPO	1.55e-03	9	197	2	C4049702
Disease	platelet component distribution width	EED SAV1 SVEP1 GAB2 EXD3 HERC1 RNF145 LNX2 RWDD3 ZNF496 BAZ2A MARK4 FGD6	1.78e-03	755	197	13	EFO_0007984
Disease	response to carboplatin, response to antineoplastic agent	SPEF2 CSMD1	1.93e-03	10	197	2	GO_0097327, GO_0097328
Disease	2-ketocaprylate measurement	ALMS1 PCNX4	1.93e-03	10	197	2	EFO_0800110
Disease	Alzheimer disease, peptic ulcer disease	CDX2 CD33 MARK4	2.24e-03	39	197	3	MONDO_0004247, MONDO_0004975
Disease	uterine fibroid	RTEL1 TNRC6B CDCA2 ZEB1 CSMD1 TNS1	2.26e-03	199	197	6	EFO_0000731
Disease	intraocular pressure measurement	GAB2 ZNF469 KMT2A BOD1L1 ARHGEF12 KANK2 OXA1L ZFHX3 TMEM26 TNS1	2.34e-03	509	197	10	EFO_0004695
Disease	Other specified cardiac arrhythmias	PKP2 HCN4	2.34e-03	11	197	2	C0348626
Disease	thyrotoxic periodic paralysis	ZFHX3 FHDC1	2.34e-03	11	197	2	MONDO_0019201
Disease	Nodal rhythm disorder	PKP2 HCN4	2.34e-03	11	197	2	C0264893
Disease	Ectopic rhythm	PKP2 HCN4	2.34e-03	11	197	2	C1399226
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 KMT2D	2.34e-03	11	197	2	DOID:3717 (is_implicated_in)
Disease	sleep disorder (implicated_via_orthology)	TFAP2A TFAP2B	2.34e-03	11	197	2	DOID:535 (implicated_via_orthology)
Disease	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	PKP2 HCN4	2.34e-03	11	197	2	C2748542
Disease	kidney disease (implicated_via_orthology)	TRPC6 UMOD HCK	2.59e-03	41	197	3	DOID:557 (implicated_via_orthology)
Disease	Prostatic Neoplasms	DAB2IP DAG1 KMT2C KMT2A ARHGEF5 KMT2D BAZ2A NCOA1 ZFHX3 PATJ MUC4	3.00e-03	616	197	11	C0033578
Disease	Malignant neoplasm of prostate	DAB2IP DAG1 KMT2C KMT2A ARHGEF5 KMT2D BAZ2A NCOA1 ZFHX3 PATJ MUC4	3.00e-03	616	197	11	C0376358
Disease	cognitive impairment measurement	DCLK2 CEP63 CSMD1	3.17e-03	44	197	3	EFO_0007998
Disease	Brugada Syndrome 1	PKP2 HCN4	3.30e-03	13	197	2	C4551804
Disease	periodontitis	DAB2IP TBC1D1 AKAP6 FAM135B ZFHX3 CSMD1	3.96e-03	223	197	6	EFO_0000649
Disease	cannabis dependence measurement	ZEB1 MEI1 CSMD1	4.06e-03	48	197	3	EFO_0008457
Disease	lung adenocarcinoma (is_implicated_in)	KMT2C PTPN13 ZFHX3	4.31e-03	49	197	3	DOID:3910 (is_implicated_in)
Disease	Sinus Node Dysfunction (disorder)	PKP2 HCN4	4.40e-03	15	197	2	C0428908
Disease	teratocarcinoma-derived growth factor 1 measurement	KMT2A TNS1	5.00e-03	16	197	2	EFO_0008297
Disease	Alzheimer disease	ANKRD31 ATXN7L1 GAB2 SRCIN1 CD33 MARK4 CSMD1 MYO15A MTSS2	5.52e-03	485	197	9	MONDO_0004975
Disease	aspartate aminotransferase to alanine aminotransferase ratio	ANKRD31 SAV1 CILP2 LILRB5 COMMD5 MARK4	5.53e-03	239	197	6	EFO_0010934
Disease	immature granulocyte count	MARK4 DEPDC5	5.65e-03	17	197	2	EFO_0803542
Disease	HbA1c measurement	CDX2 NDOR1 DAG1 GAB2 SEC16A ASCC2 PLD1 BSN ST6GAL1 FREM3 MYO15A	5.91e-03	675	197	11	EFO_0004541
Disease	facial morphology	FAM171A1 CSMD1 PHLDB2	5.96e-03	55	197	3	EFO_0004743
Disease	PR interval	EFCAB5 DAG1 ZNF469 CASKIN2 HCFC2 AKAP6 HCN4 TMEM26 PHLDB2	6.28e-03	495	197	9	EFO_0004462
Disease	Febrile seizure (within the age range of 3 months to 6 years)	HERC1 BSN	6.32e-03	18	197	2	HP_0002373
Disease	memory performance	UBE4B PXDN VSTM2A COMMD5 ARHGEF12 CBLB NT5DC2 CSMD1	6.43e-03	409	197	8	EFO_0004874
Disease	chronotype measurement	TNRC6B ZNF318 BTBD9 EXD3 PTPRG BSN GPR26 CIR1 TEX14 KMT2D CSMD1 PATJ HCK	6.56e-03	882	197	13	EFO_0008328

Protein segments in the cluster

Peptide	Gene	Start	Entry
RSPNHGTVELQGSQT	PKP4	426	Q99569
QDHTAVPTDQTGGRR	PTPRG	646	P23470
QSQHAPGSGRVRITG	nan	116	Q9HAA7
SSVRHSGGLNLAPQN	CDX2	16	Q99626
RGQSAQGTSREEPDH	CCRL2	326	O00421
SHSRDSDLGAQGSLP	CCDC116	171	Q8IYX3
GSHSGETLPLATSNQ	CSMD1	1696	Q96PZ7
QLGSSSPNFTLEGHE	COPB2	171	P35606
EGSPLSLGQSQHDLS	BAZ2A	1251	Q9UIF9
TGTVQHLRSDSFPGS	ARHGEF5	596	Q12774
SGRETISPSGDLHFQ	CEACAM21	96	Q3KPI0
AGSPRGHGQSRETTQ	ASCC2	711	Q9H1I8
SHISGQSNGRDPQAL	AGO1	826	Q9UL18
PSSTGVSNGDLLHRQ	ALMS1	2306	Q8TCU4
VAERGGQHSSSQQLP	CDRT15P3	96	P0DPF6
HRRQGSDAAVPSTGD	ARHGEF11	266	O15085
DRHDGTSNGTARLPQ	TFAP2A	16	P05549
PASGTISLDGHDIRQ	ABCB10	546	Q9NRK6
GSQHSPGRTASLNQR	ABI1	221	Q8IZP0
DSHSGRVSFLGAQLP	COMMD5	16	Q9GZQ3
DNNGAIIGPRSTRHS	DOP1A	296	Q5JWR5
HVRLQIGPGDSNDSS	DOP1A	451	Q5JWR5
PAATRAQQTGTRGHI	ADARB2-AS1	61	A8MUL3
GQAASSHEQARSSPG	FLG	1016	P20930
SASQEGQDTIRAHPG	FLG	1156	P20930
SSPGERHGSRHQQSA	FLG	1351	P20930
RQSGTRHAETSSGGQ	FLG	1651	P20930
SQEGQDTIRGHPGSS	FLG	1806	P20930
RHSQVGQGQSSGPRT	FLG	1896	P20930
RHSLVGQGQSSGPRT	FLG	2221	P20930
HSQVGQGQSEGPRTS	FLG	2546	P20930
SSPGERHGSRHQQSA	FLG	3296	P20930
DSSRHSGIPRGQASS	FLG	3311	P20930
GPHQQSHQESTRGRS	FLG	3686	P20930
SQEGQDTIRGHPGSR	FLG	3751	P20930
AHTLPRSSQGLSRGE	DDN	436	O94850
HQEESNIIGSSLGSP	DMTF1	731	Q9Y222
RHEDSPTENSEQGGR	PPP1R13B	81	Q96KQ4
ISSPGHSRQNTNRTG	ATXN7L1	841	Q9ULK2
QHGISVTGLQSPDRD	ARHGEF12	1166	Q9NZN5
DGVPSHSSRLSQLGS	TFAP2B	31	Q92481
HSSRLSQLGSVSQGP	TFAP2B	36	Q92481
HTVFDGSVLRSNSPG	RBM44	291	Q6ZP01
SGVSDTQPAGHVRSQ	RAPH1	556	Q70E73
GVNNSSHRRKNGPST	RAD17	41	O75943
QDLHATGSEPRLGTQ	RAB44	591	Q7Z6P3
RSSRDGTSNEPSHEG	IQCC	411	Q4KMZ1
TLQARDHGSPTLSAN	PCDHGB6	531	Q9Y5F9
TGVLHQRESPESDTG	KIAA1107	726	Q9UPP5
GSGAFPLDHSVTQTR	ANKRD34B	431	A5PLL1
QSPTGASESLAHQGI	ANKRD31	1626	Q8N7Z5
LRDVHTALSTPGSGQ	DAB2IP	646	Q5VWQ8
AELQGSGQRDPTHSS	DEPDC5	641	O75140
LESVGHRGPQSLSAS	FHDC1	706	Q9C0D6
LGGSQTLFHTSGQPR	MAML1	341	Q92585
ATQTGPHRATSQGTL	MUC16	6446	Q8WXI7
GDGHTTQAPTTALQA	MUC4	701	Q99102
SHGQTIQTGSRTTGR	FLG2	1936	Q5D862
REEFNSLPSGHIQGT	PTPRE	136	P23469
GTGNSTRHDLTPVTA	FAM171A1	191	Q5VUB5
QHLLVQSGSDTPSSG	KMT2C	1791	Q8NEZ4
HGNLSGTSFQQSPVR	KMT2C	3536	Q8NEZ4
NEGPHTSANVGVLSS	HCFC2	486	Q9Y5Z7
HGPSSSESTGRDLLN	MAGEB17	96	A8MXT2
LGTPHRARTSATNGT	LPAR5	311	Q9H1C0
GSRHSPAGSQALQTT	NFXL1	61	Q6ZNB6
LHSQGTGQLADGTPT	L3MBTL2	156	Q969R5
RGTATHQESDSLGEP	MYO15A	2366	Q9UKN7
TQVVSRGSHNPSLLG	ELF4	581	Q99607
RGSHNPSLLGNQTLS	ELF4	586	Q99607
RTAVGRNDTHPTTGS	CD33	291	P20138
GPNTVSNSIGDIHRN	CYP26B1	126	Q9NR63
LTGHGESIQDSRTLP	KIAA1109	1441	Q2LD37
GRLGHGDSNSRNIPT	HERC1	541	Q15751
PGNTIREAGNHSSSS	LNX2	426	Q8N448
SGTGEEQKQRPHSLS	BSN	751	Q9UPA5
AHGRSSSNVNGGPEL	DCLK2	356	Q8N568
TRLGANGSHIPQTSS	DAG1	136	Q14118
HRFLGNREPSSGQET	DDX60	276	Q8IY21
KPGITASSNVNGRHS	CBLB	616	Q13191
SGLTGDSHSQNILPV	GPR26	321	Q8NDV2
RVGDHSTGTVPENDL	PCNX4	861	Q63HM2
HGSVPNNAVLGNRTT	LRRC36	431	Q1X8D7
VGSHEQPSGATLQRR	MTSS2	381	Q765P7
FLRGSQTQSHPDLGT	PGLYRP2	231	Q96PD5
VGHSDVARTLSPGQA	PGLYRP4	346	Q96LB8
GQDSASPIRTTHTGQ	CES2	26	O00748
SNTSHPLLAVAGSRG	EED	156	O75530
SQANFTLGPVSRSHG	LILRB5	276	O75023
LQSGRRVHSVAGPSQ	OXA1L	16	Q15070
SEAGRGTETSLPNVH	DEFB118	106	Q96PH6
TQDSGGSQLLEHPSR	DMP1	251	Q13316
GGHDAPASNLTSRLS	KLHL5	661	Q96PQ7
IGARSRGSGHSQEQP	CASKIN2	701	Q8WXE0
TDHRGEQSPTDGTTL	FAM170B	6	A6NMN3
DGAQTLRRASPHSSG	HCN4	1096	Q9Y3Q4
STGSEGQRVAHPGSQ	NDOR1	186	Q9UHB4
RHPSLASSGVNGGTQ	ADCYAP1R1	431	P41586
SQQEFGHTGLPDLSS	PIPSL	751	A2A3N6
QSNHLLASGEGTQPT	IFNAR2	466	P48551
LNGTSTREQGPSRHV	MED14	731	O60244
QRLLVEHGASPSGAS	MEI1	891	Q5TIA1
TLPSRDHTGEVQRSG	MYO15B	761	Q96JP2
SPAHLRGPEQTSGQT	BOD1L1	2501	Q8NFC6
SPHNIGTSRGVQNAS	DCP1B	336	Q8IZD4
LNPTASRSGQGGTLH	ERVK-5	251	Q9HDB9
PGTHTESTLEQGSSR	EFCAB5	546	A4FU69
HNSNTPGIREAGSED	HCK	66	P08631
VGHRGAGNSTTTAQL	GPCPD1	321	Q9NPB8
GIPDTTSELAGQRDH	BRME1	501	Q0VDD7
NLGDSHSENLPGTRR	C7orf57	46	Q8NEG2
TDLHSPRGQASDSIN	CEP63	576	Q96MT8
TRSHSVGGPLQNIDF	DENND4C	1636	Q5VZ89
VLAPGNDRNSDTHGT	MARK4	6	Q96L34
SAVGARGSPETNHLI	CDCA2	91	Q69YH5
THQRSAEAQPEAGSG	FOXL1	161	Q12952
RESQHIPTAEGASGS	KANK2	566	Q63ZY3
HSSQRDLDSASGPQV	KMT2A	3466	Q03164
NSLEGGHTESNTSLP	FAM135B	726	Q49AJ0
GHTESNTSLPSGIQA	FAM135B	731	Q49AJ0
RLDLTGSSGHSLQPQ	CERCAM	576	Q5T4B2
QQLDSHALRAPSGSS	BTBD9	581	Q96Q07
SEGRLGVDTDPHTNT	CDH17	496	Q12864
IHPLSQASGGSSNIR	CDKL5	876	O76039
QQSEGSHPREKGQTT	DRP2	896	Q13474
GEESNRHRLPPNSST	LARP1B	866	Q659C4
SRGTLRHISENSFGP	PTPN13	1221	Q12923
SLAEPTEHGGRTANE	MUCL3	281	Q3MIW9
TEHGGRTANENNTPS	MUCL3	286	Q3MIW9
PVRESHGLAQGSSEE	NUTM2A	741	Q8IVF1
PVRESHGLAQGSSEE	NUTM2B	741	A6NNL0
GTHQSPSAERRGLNL	NUTM2B	796	A6NNL0
PVRESHGLAQGSSEE	NUTM2E	741	B1AL46
GTHQSPSAERRGLNL	NUTM2E	796	B1AL46
TLPTDTDGNHQVRAG	FREM3	746	P0C091
DSLRNVSSAGHGPRS	GAB2	126	Q9UQC2
RLGHRSLATGPEQSD	C8orf17	11	Q9NRJ1
SEQRAGSPGEEQAHS	RTEL1	841	Q9NZ71
SHQARGDPLSGASDR	RTL1	106	A6NKG5
HRRNTSGTPSIAVSG	SYTL5	301	Q8TDW5
GIHNGAITDSSLPTN	UTY	471	O14607
PSQEQGEALSGHRAT	UVRAG	581	Q9P2Y5
RSEHVQGSDGERSPS	SPEF2	1801	Q9C093
QGSDGERSPSRHTEE	SPEF2	1806	Q9C093
HGCRAQTSESGPSQR	TMEM26	326	Q6ZUK4
NSTGSGHSAQELPTI	URI1	371	O94763
SDQHGRQPRLGSFTS	TEX14	1016	Q8IWB6
RTRNLESNHPGQTGG	SH3D19	301	Q5HYK7
PRLQRGGSSASLHNS	SLC24A2	326	Q9UI40
SGAGFQSDPVRHLST	ABCC6	156	O95255
SESEQGLTRPHADTG	PLD1	611	Q13393
LESHGQRGQKPSQES	SYNPO	186	Q8N3V7
REHSGLSPQDDTNSG	NCOA1	366	Q15788
SPRTSDLQHRGNKGS	PELI3	11	Q8N2H9
NNSSAHGSQRTSGPE	POGZ	341	Q7Z3K3
QTQSLSHDPVSGTQG	SHROOM3	1636	Q8TF72
DDRSLVLGHQSQSSP	SHROOM4	481	Q9ULL8
SSTQDPHRGRQTLGS	ST6GAL1	66	P15907
AATPAGSRTQHLEGT	TANC1	1571	Q9C0D5
GDPHTSNSASLQGID	NHEJ1	236	Q9H9Q4
SPEGNVRGRSSEAHT	STARD9	2391	Q9P2P6
GTNPSHSLLAGESDR	PHLDB2	361	Q86SQ0
LSVSAQNSRQRHGPG	PROB1	71	E7EW31
TRSHTQGDLFPQGET	SVEP1	686	Q4LDE5
QGHRDGQRKSVSSSP	ARHGAP35	1061	Q9NRY4
SSGRSLAASGHPQAQ	SPTBN5	1581	Q9NRC6
GSRGPSPSASQREHQ	SLX4	596	Q8IY92
DGNSGTSIQSLRPHS	ABHD5	301	Q8WTS1
GQASSPSHVTRNGEV	AKAP6	606	Q13023
TASATGSEGVNLHRP	AHNAK2	5076	Q8IVF2
RDQPGTVATSDAHGT	CILP2	231	Q8IUL8
PGEEQSRRNDSRSHG	CIR1	411	Q86X95
TSLGNLTNHGSEDLP	SAV1	186	Q9H4B6
RDLSDHLSSQAGGLP	TRAF3IP3	136	Q9Y228
LRHILSQPETGSGSE	RWDD3	111	Q9Y3V2
PGNTIERGQTHSAGT	SPATS2	496	Q86XZ4
LPVLDHNGDVTGSSR	ZBTB21	811	Q9ULJ3
KQSPQSGARIATSHG	VSTM2A	206	Q8TAG5
LHPQARSVAGASSEG	ZNF324	516	O75467
QEGSSSPRSHLSPEQ	ZBTB8A	156	Q96BR9
LNGTHPSSDEGIVSR	UMOD	231	P07911
PSDGRDEVSHLQSGS	SEC16A	276	O15027
TRSSRHTQGAQPGLA	SRCIN1	116	Q9C0H9
TDGSITNGNVHRPSN	PATJ	86	Q8NI35
HGDSQTPLSQLASGR	PTGIR	316	P43119
PIGASGVAHRSQSSE	UBE4B	66	O95155
HALGSRNSPGSQVAS	XRN2	441	Q9H0D6
GSSRQSHPLTQSRSG	TNS1	751	Q9HBL0
NHVSGSRGSESPRPN	TBC1D1	201	Q86TI0
LGPRHQHSSSGASQE	FGD6	806	Q6ZV73
IPSVGRQGEHLSNST	PXDN	1356	Q92626
EPRSSSSQHPEQTGR	PRRC2B	921	Q5JSZ5
HNQGSVARGGPSATL	TESK1	331	Q15569
SAGSIPGEHSTDNNR	REL	31	Q04864
TASHEGRAPGNRELT	NT5DC2	26	Q9H857
NRHSDLSGALSSPGA	ZNF469	346	Q96JG9
LSNEHVGARASPSQG	ZEB1	1006	P37275
PDNDNSLTHGSSLGI	ZNF10	241	P21506
PRSGLLQQEASHTGE	ZNF587B	181	E7ETH6
PASHRSSTEAGGEVQ	ZNF496	386	Q96IT1
STPGDRGSQEHVDSQ	PMS2CL	136	Q68D20
SDSGNNREALSHGPR	TTC16	656	Q8NEE8
ETLQSGDHGRPNLSR	TRPC6	351	Q9Y210
QASHPQTLGARALGS	WNK2	1751	Q9Y3S1
SPNSTNHVALRDTGN	TMIGD3	121	P0DMS9
QEGSPATLQTAHSGR	XKR5	556	Q6UX68
PQGHLSQSENTFLGT	UNK	591	Q9C0B0
HTPGTRIQEGSRDNN	RNF145	616	Q96MT1
TAALTNGSDHGDLRP	ZNF438	191	Q7Z4V0
SVGNGNLHRTSSVPE	PKP2	71	Q99959
PHERASQDGSGFSRI	ZNF318	496	Q5VUA4
PRSGLLQQEASHTGE	ZNF814	181	B7Z6K7
FGNSTAQSRGLHTPV	TNRC6B	1201	Q9UPQ9
HNGGSDLERLPTAST	UBE3C	1036	Q15386
QSTGESHGPLDSLRA	ZFHX3	41	Q15911
RGHQAAATSESSPNG	WFIKKN2	306	Q8TEU8
RGTQPSLASAETSGH	ZBTB3	201	Q9H5J0
HRGAPANVSSSDLTG	CSNK1E	381	P49674
RLSGGPSSDLQNHVA	KMT2D	3461	O14686
GPSDHIDSSVTGVQR	N4BP1	581	O75113
SHQEGPRSSGDEATQ	EXD3	751	Q8N9H8
SQLGQLHSSEGTSPA	PDE4DIP	321	Q5VU43
HERLSRLESGGSNPT	PPP1R12B	831	O60237